HIV Activates the Tyrosine Kinase Hck to Secrete ADAM Protease-Containing Extracellular Vesicles

J. H. Lee, C. Ostalecki, Z. Zhao, T. Kesti, H. Bruns, B. Simon, T. Harrer, K. Saksela, A. S. Baur

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Abstract

HIV-Nef activates the myeloid cell-typical tyrosine kinase Hck, but its molecular role in the viral life cycle is not entirely understood. We found that HIV plasma extracellular vesicles (HIV pEV) containing/10 proteases and Nef also harbor Hck, and analyzed its role in the context of HIV pEV secretion. Myeloid cells required Hck for the vesicle-associated release of ADAM17. This could be induced by the introduction of Nef and implied that HIV targeted Hck for vesicle-associated ADAM17 secretion from a myeloid compartment. The other contents of HIV-pEV, however, including miRNA and effector protein profiles, as well as the presence of haptoglobin suggested hepatocytes as a possible cellular source. HIV liver tissue analysis supported this assumption, revealing induction of Hck translation, evidence for ADAM protease activation and HIV infection. Our findings suggest that HIV targets Hck to induce pro-inflammatory vesicles release and identifies hepatocytes as a possible host cell compartment.

Original languageEnglish
Pages (from-to)151-161
Number of pages11
JournaleBioMedicine
Volume28
DOIs
StatePublished - Feb 2018

Keywords

  • ADAM17
  • Chronic HIV infection
  • Hck
  • Hepatocytes
  • Liver
  • Myeloid cells
  • Nef
  • Plasma extracellular vesicles

Fingerprint

Dive into the research topics of 'HIV Activates the Tyrosine Kinase Hck to Secrete ADAM Protease-Containing Extracellular Vesicles'. Together they form a unique fingerprint.

Cite this